Gilead gets another HIV treatment approval, extending lenacapavir's dominance
Gilead Sciences' HIV treatment arsenal is getting bigger. The leading drugmaker in the four-decade epidemic gained another FDA stamp of approval on Thursday. This time, Gilead will market ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
This story
This is one outlet's version. Read the fullest account.